KBLM180 Life Sciences Corp


$ 1.86 $ -0.07 (-3.59 %)    

Monday, 09-Sep-2024 15:59:42 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 1.88
$ 1.86 x 100
-- x --
-- - --
$ 1.31 - $ 15.72
21,033
na
na
$ 0.72
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acqu...

 68-biggest-movers-from-yesterday
68 Biggest Movers From Yesterday
11/09/2020 10:18:42

Gainers

 51-biggest-movers-from-yesterday
51 Biggest Movers From Yesterday
11/05/2020 10:15:58

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 51.2% to close at $16.98 on Wednesday. Aptevo Therapeutics, on...

 54-biggest-movers-from-yesterday
54 Biggest Movers From Yesterday
11/04/2020 10:04:43

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) climbed 78.3% to close at $11.23 on Tuesday after the company issued an upda...

Core News & Articles

Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Pa...

Core News & Articles

Gainers KBL Merger IV (NASDAQ:KBLM) stock increased by 36.85% to $11.09 during Friday's regular session. As of 12:31 EST, ...

Core News & Articles

KBL Merger (NASDAQ: KBLM) shares are trading higher on Friday after 180 Life Sciences announced a merger deal with the company.

Core News & Articles

180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Me...

Core News & Articles

  Before 10 a.m. ET on Wednesday, 21 companies set new 52-week lows.

Core News & Articles

180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents The company's patent portfolio includes it...

Core News & Articles

180 Life Sciences Corp. Leading Research into Novel Drug Therapies Expected to Produce First Results of Phase 2b/3 Trial in 202...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION